These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27597380)
1. Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study. Mangili G; Ottolina J; Cormio G; Loizzi V; De Iaco P; Pellegrini DA; Candiani M; Giorda G; Scarfone G; Cecere SC; Frigerio L; Gadducci A; Marchetti C; Ferrandina G Gynecol Oncol; 2016 Nov; 143(2):276-280. PubMed ID: 27597380 [TBL] [Abstract][Full Text] [Related]
2. Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary? Wang D; Xiang Y; Wu M; Shen K; Yang J; Huang H; Ren T J Ovarian Res; 2018 Mar; 11(1):25. PubMed ID: 29587835 [TBL] [Abstract][Full Text] [Related]
4. Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Park JY; Jin KL; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH Gynecol Oncol; 2012 Apr; 125(1):80-6. PubMed ID: 22210469 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Mangili G; Ottolina J; Gadducci A; Giorda G; Breda E; Savarese A; Candiani M; Frigerio L; Scarfone G; Pignata S; Rossi R; Marinaccio M; Lorusso D Br J Cancer; 2013 Jul; 109(1):29-34. PubMed ID: 23756859 [TBL] [Abstract][Full Text] [Related]
14. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258 [TBL] [Abstract][Full Text] [Related]
15. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study. Erdogan O; Kilic C; Cakir C; Kilic F; Oktar O; Ersak B; Sahin M; Tokalioglu A; Kocak O; Ozturk C; Gorgulu G; Gokkaya M; Selcuk I; Korkmaz V; Comert GK; Toptas T; Ureyen I; Ucar G; Taskin S; Tasci T; Uncu D; Narin MA; Boran N; Ozdal B; Tekin OM; Ustun Y; Sancı M; Ortac F; Turan T Asia Pac J Clin Oncol; 2024 Feb; 20(1):46-54. PubMed ID: 37096294 [TBL] [Abstract][Full Text] [Related]
16. Adult Granulosa Cell Tumors of the Ovary: A Retrospective Study of 36 FIGO Stage I Cases with Emphasis on Prognostic Pathohistological Features. Babarović E; Franin I; Klarić M; Ferrari AM; Karnjuš-Begonja R; Eminović S; Ostojić DV; Vrdoljak-Mozetič D Anal Cell Pathol (Amst); 2018; 2018():9148124. PubMed ID: 30186737 [TBL] [Abstract][Full Text] [Related]
17. Granulosa cell tumors of the ovary: prognostic factors and outcome. Malmström H; Högberg T; Risberg B; Simonsen E Gynecol Oncol; 1994 Jan; 52(1):50-5. PubMed ID: 8307501 [TBL] [Abstract][Full Text] [Related]
18. [Long-term outcome analysis in the treatment of granulosa cell tumors]. Rzepka J; Kuc-Rajca M; Zalewski K; Dańska-Bidzińska A; Bidziński M Ginekol Pol; 2012 Jul; 83(7):505-10. PubMed ID: 22880474 [TBL] [Abstract][Full Text] [Related]
19. Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study. Bergamini A; Cormio G; Ferrandina G; Lorusso D; Giorda G; Scarfone G; Bocciolone L; Raspagliesi F; Tateo S; Cassani C; Savarese A; Breda E; De Giorgi U; Mascilini F; Candiani M; Kardhashi A; Biglia N; Perrone AM; Pignata S; Mangili G Gynecol Oncol; 2019 Aug; 154(2):323-327. PubMed ID: 31189500 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study. Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]